Study shows drug reduces heart attack risk by 40%
Ivabradine, manufactured in Co Wicklow, has also cut the incidence of heart surgery and other surgical procedures by more than half in angina patients, according to a global study on heart disease.
The results of the research – known as the BEAUTIFUL study – were presented yesterday at the European Society of Cardiology (ESC) Congress in Barcelona.